Clinical Trial: Telehealth in Motor Neurone Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Telehealth in Motor Neurone Disease: A Single Centre, Randomised Controlled Feasibility and Pilot Study of the Use of the TiM Telehealth System to Deliver Highly Specialis

Brief Summary:

Motor neurone disease (MND) is a rare but debilitating neurological condition that causes paralysis of the body's muscles leading to severe disability and eventually death. Patients often struggle to travel the long distances to specialist clinics to receive the care they require whilst this expert care is often unavailable in the community. Telehealth has the potential to enable a specialist team to monitor the health and wellbeing of patients and their carers whilst they are at home. This could improve the patient's health, improve the quality of life of both patients and their carers, and lead to more effective use of health resources.

This is a randomised controlled pilot study that will involve 40 patients who are cared for by the Sheffield Motor Neurone Disease care centre and their main informal carer (a total of 80 participants). Half of the participants will use the telehealth system for a minimum of six months and maximum of eighteen months and information will be collected from patients, carers and their care team. This will include collecting clinical outcome measures, health resource use and the opinions and experience of using the system. All participants will continue to receive their usual care.

This is a pilot study. It aims to determine the feasibility and acceptability of the telehealth system to patients, carers and their health care providers. It also aims to determine how a larger trial could successfully evaluate the clinical and cost-effectiveness of the system.


Detailed Summary: MND is often referred to as amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust

Current Primary Outcome: Feasibility and acceptability of using the telehealth system from interviews [ Time Frame: Up to 18 months ]

Recruitment rate, retention rate.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Sheffield Teaching Hospitals NHS Foundation Trust

Dates:
Date Received: November 13, 2014
Date Started: September 2014
Date Completion:
Last Updated: April 26, 2017
Last Verified: April 2017